Veritable, L.P. Edwards Lifesciences Corp Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $147,514 - $170,925	-1,812 Reduced 11.86%	13,465 $1.27 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $115,103 - $130,990	1,550 Added 11.29%	15,277 $1.26 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $25,680 - $32,877	-376 Reduced 2.67%	13,727 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $33,524 - $43,667	-407 Reduced 2.8%	14,103 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $92,901 - $137,761	-1,074 Reduced 6.89%	14,510 $1.38 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $32,219 - $40,555	316 Added 2.07%	15,584 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $22,975 - $28,226	216 Added 1.44%	15,268 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $4,939 - $5,892	48 Added 0.32%	15,052 $1.7 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $20,456 - $25,561	244 Added 1.65%	15,004 $1.55 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $129,664 - $149,424	-1,648 Reduced 10.04%	14,760 $1.24 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $47,100 - $59,938	-657 Reduced 3.85%	16,408 $1.5 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $67 - $87	1 Added 0.01%	17,065 $1.36 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $614,642 - $821,979	10,682 Added 167.38%	17,064 $1.18 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $42,085 - $65,043	-803 Reduced 11.18%	6,382 $1.2 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $45,242 - $51,798	631 Added 9.63%	7,185 $1.68 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $59,518 - $72,940	967 Added 17.31%	6,554 $1.44 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $1,449 - $1,674	-26 Reduced 0.46%	5,587 $1.03 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $8,668 - $11,593	181 Added 3.33%	5,613 $1.07 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $14,340 - $17,594	-309 Reduced 5.38%	5,432 $832,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $41,267 - $52,401	-903 Reduced 13.59%	5,741 $1 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $31,243 - $37,756	-736 Reduced 9.97%	6,644 $967,000
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $25,177 - $32,123	-677 Reduced 8.4%	7,380 $1.03 Million
Q4 2017 Feb 13, 2018	BUY	$33.79 - $39.39 $62,173 - $72,477	1,840 Added 29.6%	8,057 $908,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $225,614 - $241,406	6,217	6,217 $680,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account